Cellectis (CLLS) Return on Capital Employed Growth (3y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -494.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -649.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4,853.00 |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2,384.00 |
| Jun 30, 2025 | 1,464.00 |
| Sep 30, 2024 | 276.00 |
| Jun 30, 2024 | -837.00 |
| Mar 31, 2024 | -2,129.00 |
| Dec 31, 2023 | -6,278.00 |
| Sep 30, 2023 | -2,021.00 |
| Jun 30, 2023 | -1,939.00 |
| Sep 30, 2022 | -1,119.00 |
| Jun 30, 2022 | -1,275.00 |
| Sep 30, 2021 | -1,458.00 |
| Jun 30, 2021 | -573.00 |
| Mar 31, 2021 | 481.00 |
| Dec 31, 2020 | 1,098.00 |
| Sep 30, 2020 | 966.00 |
| Jun 30, 2020 | 737.00 |
| Mar 31, 2020 | 266.00 |
| Dec 31, 2019 | -668.00 |
| Sep 30, 2019 | -1,032.00 |
| Jun 30, 2019 | -861.00 |
| Mar 31, 2019 | -505.00 |
| Dec 31, 2018 | -1,113.00 |